Both medications are administered via injection and work to promote weight loss by reducing appetite, enhancing feelings of fullness, and regulating blood sugar levels
FDA and National Institutes of Health (NIH) for the most reliable guidelines
Ill mention them here, as they do provide more insight into Novos pipeline
Instead, take a dose as soon as you remember
Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs)along with the dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1RA tirzepatideare widely acknowledged for their efficacy in managing both type 2 diabetes mellitus and obesity, with expanding indications in cardiometabolic risk reduction
One honest note: this study compared Mounjaro against the higher, weight-loss dose of semaglutide, the one sold as Wegovy